comprehensive -WSS

comprehensive

author：leisure time 2025-08-11 11:45:35 - browse：69

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： National panel will explore requiring free Covid tests

WSS

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

What the US credit downgrade means for the economy, your finances

Independent physicians launch a new lobbying group

Prior authorization will have to move faster under new Biden rule

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

focus

comprehensive

explore

Drug repurposing or repositioning? The language matters

New safety details link Apellis eye drug to rare cases of blindness

The high cost of giving birth even with insurance

Wildfire pollution widens asthma inequities on Long Island

Heart attack and stroke risk calculators need revising

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Trump demands the U.S. pay no more for drugs than other countries … again

NIH launches clinical trials and new research office for long Covid

What does generative AI mean for health care? We asked experts

Think you might have Covid

explore

Why doctors need education on FDA device approval process

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Eli Lilly, Pfizer, and others want in on the online prescription market

NIH director takes cautious approach to Biden drug pricing priority

Trump indictment: Who are the 'co

Pence says 'crackpot lawyers' told Trump what he wanted to hear

focus

hotspot

knowledge

Wikipedia